2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …
F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …
exercising their clinical judgment, as well as in the determination and the implementation of …
2018 ESC/EACTS Guidelines on myocardial revascularization
M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …
Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …
Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …
extensive review was conducted on literature published through March 1, 2020. Searches …
2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American …
CM Otto, RA Nishimura, RO Bonow… - Journal of the American …, 2021 - jacc.org
Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …
recommendations for clinicians to diagnose and manage valvular heart disease as well as …
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the …
DJFM Thuijs, AP Kappetein, PW Serruys, FW Mohr… - The Lancet, 2019 - thelancet.com
Summary Background The Synergy between PCI with Taxus and Cardiac Surgery
(SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention …
(SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention …
2018 ESC/EACTS Guidelines on myocardial revascularization
FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the …
NR Holm, T Mäkikallio, MM Lindsay, MS Spence… - The Lancet, 2020 - thelancet.com
Background Percutaneous coronary intervention (PCI) is increasingly used in
revascularisation of patients with left main coronary artery disease in place of the standard …
revascularisation of patients with left main coronary artery disease in place of the standard …
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
R Al-Lamee, D Thompson, HM Dehbi, S Sen, K Tang… - The Lancet, 2018 - thelancet.com
Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …